Vyome Holdings, Inc. (NASDAQ:HIND) — Market Cap & Net Worth
Market Cap & Net Worth: Vyome Holdings, Inc. (HIND)
Vyome Holdings, Inc. (NASDAQ:HIND) has a market capitalization of $13.76 Million ($13.76 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #26334 globally and #5497 in its home market, demonstrating a -4.85% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vyome Holdings, Inc.'s stock price $1.96 by its total outstanding shares 7018528 (7.02 Million). Also see Vyome Holdings, Inc. asset portfolio for a full breakdown of the balance sheet.
Vyome Holdings, Inc. Market Cap History: 2025 to 2026
Vyome Holdings, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $24.14 Million to $13.76 Million (0.00% CAGR). Also see HIND operating cash flow for how efficiently the company converts equity into cash flow.
Vyome Holdings, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vyome Holdings, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check HIND stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
75.52x
Vyome Holdings, Inc.'s market cap is 75.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $24.14 Million | $319.71K | -$10.26 Million | 75.52x | N/A |
Competitor Companies of HIND by Market Capitalization
Companies near Vyome Holdings, Inc. in the global market cap rankings as of September 18, 2026. Review HIND goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Vyome Holdings, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
Vyome Holdings, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Vyome Holdings, Inc.'s market cap moved from $24.14 Million to $ 13.76 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.76 Million | -43.02% |
| 2025 | $24.14 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Vyome Holdings, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.76 Million USD |
| MoneyControl | $13.76 Million USD |
| MarketWatch | $13.76 Million USD |
| marketcap.company | $13.76 Million USD |
| Reuters | $13.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vyome Holdings, Inc.
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinica… Read more